Library / regulatory-reference
Denmark: Danish Medicines Agency (Laegemiddelstyrelsen)
Audience: administrators-policy, researchers-scientists ยท Review state: published
The national authority
The Danish Medicines Agency, known in Danish as Laegemiddelstyrelsen, is Denmark's national regulatory authority for medicines and medical devices, operating under the Ministry of the Interior and Health.
Denmark hosts a globally significant pharmaceutical industry, and the agency's licensing and inspection oversight of manufacturers gives its work international reach.
How products enter the market
Medicines require marketing authorization through national or European procedures after evaluation of quality, safety and efficacy, and establishments are licensed and inspected by the agency.
Post-market work includes safety monitoring within the European alert network, and the agency is known for publishing accessible data on medicine use and pricing.
Regional and international role
The agency is a senior member of the European regulatory network, contributing assessments and inspections to shared European work.
Its oversight of globally supplying manufacturers, including some of the world's most-used medicine franchises, makes its inspection outcomes relevant worldwide.
Using this profile
The agency publishes regulations, registers and alerts in Danish, with substantial English material, through its official portal, which is the primary source for current rules and listed in this profile's internal reference record.
For cross-country comparison: Denmark illustrates the industry-hosting regulator: a national agency whose certificates underpin some of the world's largest medicine supply chains.
Limitations
Educational profile of a national regulatory system, current as of drafting. It simplifies routes and classes and is not legal, regulatory, or clinical advice. Filing and compliance decisions must be confirmed against the authority's current published rules and, where needed, professional regulatory counsel.